Results 111 to 120 of about 461 (125)

Neues Mittel Cagrilintid boostert Semaglutid

MMW - Fortschritte der Medizin
openaire   +1 more source

Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models

Biomedicine and Pharmacotherapy, 2022
exaly  

Stärkere Gewichtsreduktion durch Cagrilintid plus Semaglutid

CardioVasc
openaire   +1 more source

Cagrilintide and CagriSema for weight reduction and metabolic risk modification in overweight or obesity: a systematic review and meta-analysis

Journal of Diabetes & Metabolic Disorders
Hammad Rao, Sumet Kumar, Sheikh Muhammad Ebtehaj Ali, Harmain Muhammad Asif, Mukesh Kumar, Laksh Kumar, Adarsh Raja   +6 more
openaire   +1 more source

Review for "Efficacy and Safety of Cagrilintide and Cagrisema versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression"

  +5 more sources

Cagrilintide-Semaglutide in Adults with Overweight or Obesity. Reply.

The New England journal of medicine
W Timothy, Garvey, Cynthia Karenina, Osorto Contreras, Melanie J, Davies   +2 more
openaire   +2 more sources

Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3

EBioMedicine
Christelle Le Foll, Bernd Coester, Kirsten Raun   +2 more
exaly  

Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants

Diabetes, Obesity and Metabolism
Tine Bækdal, Rainard Fuhr
exaly  

Author response for "Efficacy and Safety of Cagrilintide and Cagrisema versus Semaglutide as Anti-Obesity Medications: A Systematic Review, Meta-Analysis and Meta-Regression"

null Muhammad Ahmed, null Muhammad Hassan, null Muhammad Tahir, null Muhammad Hussain, null Faisal Islam, null Ghulam Taha Khan, null Muhammad Ahsan, null Shaheer Bin Shafiq, null Ahmed Ibrahim, null Ammad Uddin, null Saad Ahmed Waqas   +10 more
openaire   +1 more source

26-A-9711-ACC CAGRISEMA VERSUS CAGRILINTIDE OR SEMAGLUTIDE MONOTHERAPY AS ANTI-OBESITY MEDICATIONS: A SYSTEMATIC REVIEW AND BAYESIAN NETWORK META-ANALYSIS WITH TRIAL SEQUENTIAL ANALYSIS

JACC
Bara Hammadeh, Nesreen Alhamwi, Layan Sufian Aldib, Sima Rawal, Naser Mahmoud   +4 more
openaire   +1 more source